Reaction
Meibomian Gland Dysfunction reporting signals
As of the last recalculation, Meibomian Gland Dysfunction appears in 435 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is CARBOXYMETHYLCELLULOSE SODIUM (PRR 57.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Carboxymethylcellulose Sodium | 11 | 57.4 | 57.5 |
| Brimonidine Tartrate | 14 | 38.8 | 38.8 |
| Pertuzumab | 18 | 33.0 | 33.0 |
| Isotretinoin | 29 | 30.0 | 30.0 |
| Lifitegrast | 10 | 30.0 | 30.0 |
| Selinexor | 5 | 27.9 | 28.0 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 6 | 23.3 | 23.3 |
| Erlotinib | 4 | 19.9 | 19.9 |
| Erlotinib Hydrochloride | 5 | 19.3 | 19.3 |
| Asfotase Alfa | 4 | 19.3 | 19.3 |
| Bimatoprost | 11 | 18.7 | 18.7 |
| Minoxidil Foam 5% (Womens) | 6 | 8.8 | 8.8 |
| Minoxidil | 6 | 6.5 | 6.5 |